Cargando…

A Screening of the MMV Pandemic Response Box Reveals Epetraborole as A New Potent Inhibitor against Mycobacterium abscessus

Mycobacterium abscessus is the one of the most feared bacterial respiratory pathogens in the world. Unfortunately, there are many problems with the current M. abscessus therapies available. These problems include misdiagnoses, high drug resistance, poor long-term treatment outcomes, and high costs....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Taeho, Hanh, Bui-Thi-Bich, Heo, Boeun, Quang, Nguyenthanh, Park, Yujin, Shin, Jihyeon, Jeon, Seunghyeon, Park, June-Woo, Samby, Kirandeep, Jang, Jichan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199016/ https://www.ncbi.nlm.nih.gov/pubmed/34073006 http://dx.doi.org/10.3390/ijms22115936

Ejemplares similares

Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
por: Bich Hanh, Bui Thi, et al.
Publicado: (2021)

Actives from MMV Open Access Boxes? A suggested way forward
por: Samby, Kirandeep, et al.
Publicado: (2021)

Epetraborole Is Active against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021)

In Vitro Activities of MMV Malaria Box Compounds against the Apicomplexan Parasite Neospora caninum, the Causative Agent of Neosporosis in Animals
por: Müller, Joachim, et al.
Publicado: (2020)

CRISPR Interference-Based Inhibition of MAB_0055c Expression Alters Drug Sensitivity in Mycobacterium abscessus
por: Nguyen, Thanh Quang, et al.
Publicado: (2023)

Efficacy of epetraborole against Mycobacterium abscessus is increased with norvaline
por: Sullivan, Jaryd R., et al.
Publicado: (2021)

Rifamycin O, An Alternative Anti-Mycobacterium abscessus Agent
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020)

Etamycin as a Novel Mycobacterium abscessus Inhibitor
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020)

Screening of the Pandemic Response Box Reveals an Association between Antifungal Effects of MMV1593537 and the Cell Wall of Cryptococcus neoformans, Cryptococcus deuterogattii, and Candida auris
por: de Oliveira, Haroldo C., et al.
Publicado: (2022)

2064. In Vitro Susceptibility of Recent Mycobacterium abscessus Isolates to Epetraborole (EBO) and Comparators by Broth Microdilution
por: Nguyen, Minh-Vu H, et al.
Publicado: (2023)

Thiostrepton: A Novel Therapeutic Drug Candidate for Mycobacterium abscessus Infection
por: Kim, Tae Ho, et al.
Publicado: (2019)

In Vitro Profiling of the Synthetic RNA Polymerase Inhibitor MMV688845 against Mycobacterium abscessus
por: Mann, Lea, et al.
Publicado: (2022)

Identification of β-hematin inhibitors in the MMV Malaria Box
por: Fong, Kim Y., et al.
Publicado: (2015)

Pathogen Box screening for hit identification against Mycobacterium abscessus
por: Jeong, Jinsun, et al.
Publicado: (2018)

Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus
por: Quang, Nguyen Thanh, et al.
Publicado: (2021)

Sirtuin 3 is essential for host defense against Mycobacterium abscessus infection through regulation of mitochondrial homeostasis
por: Kim, Young Jae, et al.
Publicado: (2020)

The Peroxisome Proliferator-Activated Receptor α- Agonist Gemfibrozil Promotes Defense Against Mycobacterium abscessus Infections
por: Kim, Yi Sak, et al.
Publicado: (2020)

Ohmyungsamycin promotes M1-like inflammatory responses to enhance host defence against Mycobacteroides abscessus infections
por: Jeon, Sang Min, et al.
Publicado: (2022)

Stepwise in vitro screening of MMV pathogen box compounds against Plasmodium falciparum to identify potent antimalarial candidates
por: Mbye, Haddijatou, et al.
Publicado: (2023)

Preliminary Structure–Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 (2,4-Diaminoquinazoline) Unveils Novel Inhibitors of Trypanosoma brucei brucei
por: Dize, Darline, et al.
Publicado: (2022)

Discovery of New Chemical Tools against Leishmania amazonensis via the MMV Pathogen Box
por: López-Arencibia, Atteneri, et al.
Publicado: (2021)

MMV in partnership: the Eurartesim(®) experience
por: Ubben, David, et al.
Publicado: (2013)

Identification of MMV Malaria Box Inhibitors of Perkinsus marinus Using an ATP-Based Bioluminescence Assay
por: Alemán Resto, Yesmalie, et al.
Publicado: (2014)

New Derivatives of the Multi-Stage Active Malaria Box Compound MMV030666 and Their Antiplasmodial Potencies
por: Hermann, Theresa, et al.
Publicado: (2022)

Screening of MMV pandemic response and pathogen box compounds against pan-drug-resistant Klebsiella pneumoniae to identify potent inhibitory compounds
por: Sivasankar, Seshan, et al.
Publicado: (2023)

Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box
por: Reader, Janette, et al.
Publicado: (2021)

A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis
por: Coelho, Rowena Alves, et al.
Publicado: (2020)

Diaminoquinazoline MMV675968 from Pathogen Box inhibits Acinetobacter baumannii growth through targeting of dihydrofolate reductase
por: Songsungthong, Warangkhana, et al.
Publicado: (2019)

MMV560185 from pathogen box induces extrinsic pathway of apoptosis in Theileria annulata infected bovine leucocytes
por: Araveti, Prasanna Babu, et al.
Publicado: (2022)

New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box(®) that present synergism with itraconazole
por: Coelho, Rowena Alves, et al.
Publicado: (2022)

Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on Balamuthia mandrillaris, Naegleria fowleri, and Acanthamoeba castellanii
por: Rice, Christopher A., et al.
Publicado: (2020)

Repurposing the Medicines for Malaria Venture’s COVID Box to discover potent inhibitors of Toxoplasma gondii, and in vivo efficacy evaluation of almitrine bismesylate (MMV1804175) in chronically infected mice
por: dos Santos, Bruna Ramos, et al.
Publicado: (2023)

Identification of Plasmodium falciparum specific translation inhibitors from the MMV Malaria Box using a high throughput in vitro translation screen
por: Ahyong, Vida, et al.
Publicado: (2016)

Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183
por: de Vries, Laura E., et al.
Publicado: (2022)

2135. Epetraborole in vitro Activity Against Mycobacterium avium complex Recent Clinical Isolates from Japan
por: White, Tiffany Keepers, et al.
Publicado: (2023)

2556. A Phase 1, Open-Label, Single Dose Study to Evaluate the Pharmacokinetics (PK), Safety, and Tolerability of Epetraborole Tablets and the Impact of Alcohol Dehydrogenase (ADH) Genotype on the PK of Epetraborole and Metabolite M3 in Healthy Japanese Adult Subjects
por: Patel, Gina, et al.
Publicado: (2023)

Mixed Infection of Mycobacterium abscessus subsp. abscessus and Mycobacterium tuberculosis in the Lung
por: Sohn, Sungmin, et al.
Publicado: (2017)

Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics
por: Ghidelli-Disse, Sonja, et al.
Publicado: (2014)

Efficacy, Safety, Tolerability, and Pharmacokinetics of MMV390048 in Acute Uncomplicated Malaria
por: Mohammed, Rezika, et al.
Publicado: (2023)

Mycobacterium abscessus activates the NLRP3 inflammasome via Dectin-1–Syk and p62/SQSTM1
por: Lee, Hye-Mi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1548fmd877ga12r82ecjndud6m